Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment

This thesis report is submitted in partial fulfillment of the requirement for the degree of Master of Science in Biotechnology, 2022.

書目詳細資料
主要作者: Shaikat, Mahdi Mubin
其他作者: Bin Naser, Dr. Iftekhar
格式: Thesis
語言:English
出版: Brac University 2023
主題:
在線閱讀:http://hdl.handle.net/10361/18984
id 10361-18984
record_format dspace
spelling 10361-189842023-07-24T21:02:02Z Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment Shaikat, Mahdi Mubin Bin Naser, Dr. Iftekhar Department of Mathematics and Natural Sciences, Brac University CRISPR/Cas9 Genome editing Cancer Vectors Onco genes Cancer treatment Gene editing--Technological innovations. Cancer--Treatment This thesis report is submitted in partial fulfillment of the requirement for the degree of Master of Science in Biotechnology, 2022. Cataloged from PDF version of thesis. Includes bibliographical references (pages 54-63). One of the biggest causes of mortality worldwide is cancer. Cancer is one of the most challenging diseases to cure because of its capacity to spread quickly, metastasis, and create diverse tumors as a result of mutagenesis events. The gene editing tool Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) systems and CRISPR-associated (Cas) enzymes have demonstrated enormous potential in the treatment of genome-based disorders, particularly cancer, due to their great precision and efficiency. CRISPR-Cas systems can find fresh targets for brand new prospective anti-cancer therapies thanks to their capacity to purposefully activate or repress genes. The mechanisms of the various kinds of CRISPR-Cas systems are outlined in this paper. This study also covers a number of additional uses for CRISPR-Cas systems in the realm of cancer, including as diagnostic and therapeutic uses. Mahdi Mubin Shaikat M. Biotechnology 2023-07-24T06:44:54Z 2023-07-24T06:44:54Z 2022 2022-12 Thesis ID: 21176005 http://hdl.handle.net/10361/18984 en Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. 63 pages application/pdf Brac University
institution Brac University
collection Institutional Repository
language English
topic CRISPR/Cas9
Genome editing
Cancer
Vectors
Onco genes
Cancer treatment
Gene editing--Technological innovations.
Cancer--Treatment
spellingShingle CRISPR/Cas9
Genome editing
Cancer
Vectors
Onco genes
Cancer treatment
Gene editing--Technological innovations.
Cancer--Treatment
Shaikat, Mahdi Mubin
Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
description This thesis report is submitted in partial fulfillment of the requirement for the degree of Master of Science in Biotechnology, 2022.
author2 Bin Naser, Dr. Iftekhar
author_facet Bin Naser, Dr. Iftekhar
Shaikat, Mahdi Mubin
format Thesis
author Shaikat, Mahdi Mubin
author_sort Shaikat, Mahdi Mubin
title Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
title_short Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
title_full Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
title_fullStr Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
title_full_unstemmed Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
title_sort prevalence and application of an evolving genome editing tool “crispr/cas system” in cancer research and treatment
publisher Brac University
publishDate 2023
url http://hdl.handle.net/10361/18984
work_keys_str_mv AT shaikatmahdimubin prevalenceandapplicationofanevolvinggenomeeditingtoolcrisprcassystemincancerresearchandtreatment
_version_ 1814308248697700352